Full Description
Diabetic Nephropathy: Recent Therapeutic Targets for the Prevention and Management of Diabetic Complications is an essential resource to better understand neuropathy in depth. It combines scientific literature and potential therapeutic solutions to approach the management of this specific diabetic health complication. It is a detailed reference to understand the pathogenesis of diabetes to alleviate the complications of nephropathy (kidney disease) can bring. It's focused on all aspects of nephropathy with an emphasis on the molecular and biological pathways (therapeutic target) for the potential to detect an early diagnosis. The book is useful to anyone in the field particularly those who do research investigations, and day-to-day practice in the area of diabetes.
Contents
1. Challenges in Pathogenesis, Diagnosis, and Treatment of Diabetic Nephropathy: An Update
2. Roles and Cross Talks of Macrophages in Diabetic Nephropathy
3. AMPK Allostery: A Therapeutic Target for the Management or Treatment of Diabetic Nephropathy
4. Autophagy Regulation as Therapeutic Target for Diabetic Nephropathy
5. MicroRNA and Circular RNA as New Generation Therapeutic Targets in the Management of Diabetic Nephropathy
6. Caveolin-1 in the Pathogenesis and as a Therapeutic Target for Diabetic Nephropathy
7. Exosome, a Major Extracellular Vesicle, as a Therapeutic Strategy for Diabetic Nephropathy
8. Deletion of Smad3 as a Therapeutic Target for the Prevention of Renal Fibrosis and Inflammation in Diabetic Nephropathy
9. Myokines and Mitochondrial DNA as Some Novel Therapeutic Targets for the Management of Diabetic Nephropathy
10. Activation of Nrf2 Signaling Pathway as a Therapeutic Target for the Amelioration of Diabetic Nephropathy
11. YY1 as a Novel Therapeutic Target for the Prevention of Renal Fibrosis in Diabetic Nephropathy
12. Microbubbles and Ultrasound Mediated Gene Delivery as a Novel Therapeutic Approach for the Treatment of Diabetic Nephropathy
13. Human Antigen R as a Novel Therapeutic Target for the Management of Diabetic Nephropathy
14. Farnesoid X Receptor as a Potential Therapeutic Target for the Treatment of Diabetic Kidney Disease
15. SET7, a Lysine-Specific Methyl Transferase as an Epigenetic Target for the Treatment of Diabetic Nephropathy
16. DNA Methyltransferase 1 as a Therapeutic Target for Attenuating Diabetic Nephropathy
17. Roles of Non-Coding RNA CYP4B1-PS1-001 in Regulating the Proliferation of Renal Fibrosis in Diabetic Nephropathy
18. Bioactive Pure Phytochemicals in the Management and Treatment of Diabetic Nephropathy
19. Oxidative Stress and Antioxidant Defense as a Target for the Management of Diabetic Kidney Disease
20. Roles of mTOR Inhibitors in the Management of Renal Cancer and Diabetic Kidney Disease
